Skip to main content

Table 1 Tissue-specific differentiation antigens

From: Tumor Antigens Discovery: Perspectives for Cancer Therapy

Antigens HLA restrictions Peptides Comments
Tyrosinase HLA-A2 MLLAVLYCL  
HLA-A2 YMNGTMSQV
HLA-B44 SEIWRDIDF
HLA-A24 AFLPWHRLF
HLA-DR4 QNILLSNAPLGPQFP
HLA-DR4 SYLQDSDPDSFQD
MART-1/Melan-A gP100 HLA-A2 AAGIGILTV
HLA-A2 KTWGQYWQV
HLA-A2 ITDQVPFSV
HLA-A2 YLEPGPVTA
HLA-A2 LLDGTATLRL
HLA-A2 VLYRYGSFSV
HLA-A3 ALLAVGATK
HLA-A2 VYFFLPDHL Epitope generated from an intron of an incomplete splicing RNA
gP75/TRP-1 HLA-A31 MSLQRQFLR Epitope was derived from an alternative ORF
TRP-2 HLA-A31 LLGPGRPYR Mouse TRP-2 was identified as a tumor antigen for B16 melanoma